Результати пошуку - Scott R. Plotkin
- Показ 1 - 20 результатів із 57
- На наступну сторінку
-
1
-
2
Increased Risk of Cerebrovascular Disease Among Patients With Neurofibromatosis Type 1 за авторством Anna R. Terry, Justin T. Jordan, Lee H. Schwamm, Scott R. Plotkin
Опубліковано 2015Artigo -
3
-
4
Exacerbation of Cerebral Radiation Necrosis by Bevacizumab за авторством Deva S. Jeyaretna, William T. Curry, Tracy T. Batchelor, Anat Stemmer‐Rachamimov, Scott R. Plotkin
Опубліковано 2010Artigo -
5
Glioblastoma care in the elderly за авторством Justin T. Jordan, Elizabeth R. Gerstner, Tracy T. Batchelor, Daniel P. Cahill, Scott R. Plotkin
Опубліковано 2015Revisão -
6
-
7
Clinical Features of Schwannomatosis: A Retrospective Analysis of 87 Patients за авторством Vanessa L. Merker, Sonia Esparza, Miriam J. Smith, Anat Stemmer‐Rachamimov, Scott R. Plotkin
Опубліковано 2012Artigo -
8
-
9
Erlotinib for Progressive Vestibular Schwannoma in Neurofibromatosis 2 Patients за авторством Scott R. Plotkin, Chris Halpin, Michael J. McKenna, Jay S. Loeffler, Tracy T. Batchelor, Fred G. Barker
Опубліковано 2010Artigo -
10
Expression of SMARCB1 (INI1) mutations in familial schwannomatosis за авторством Miriam J. Smith, James A. Walker, Yiping Shen, Anat Stemmer‐Rachamimov, James F. Gusella, Scott R. Plotkin
Опубліковано 2012Artigo -
11
Emotional functioning of patients with neurofibromatosis tumor suppressor syndrome за авторством Daphne L. Wang, Kelly B. Smith, Sonia Esparza, Fawn A. Leigh, Alona Muzikansky, Elyse R. Park, Scott R. Plotkin
Опубліковано 2012Artigo -
12
Bevacizumab for Progressive Vestibular Schwannoma in Neurofibromatosis Type 2 за авторством Scott R. Plotkin, Vanessa L. Merker, Chris Halpin, Dominique Jennings, Michael J. McKenna, Gordon J. Harris, Fred G. Barker
Опубліковано 2012Artigo -
13
-
14
NF2/Merlin Is a Novel Negative Regulator of mTOR Complex 1, and Activation of mTORC1 Is Associated with Meningioma and Schwannoma Growth за авторством Marianne F. James, Sangyeul Han, Carolyn Polizzano, Scott R. Plotkin, Brendan D. Manning, Anat Stemmer‐Rachamimov, James F. Gusella, Vijaya Ramesh
Опубліковано 2009Artigo -
15
Achieving consensus for clinical trials за авторством Scott R. Plotkin, Jaishri O. Blakeley, Eva Dombi, Michael J. Fisher, C. Oliver Hanemann, Karin S. Walsh, Pamela L. Wolters, Brigitte C. Widemann
Опубліковано 2013Revisão -
16
Treatment of Relapsed Central Nervous System Lymphoma with High-Dose Methotrexate за авторством Scott R. Plotkin, Rebecca A. Betensky, Fred H. Hochberg, Stuart A. Grossman, Glenn J. Lesser, Burt Nabors, Brian H. Chon, Tracy T. Batchelor
Опубліковано 2004Artigo -
17
Anti–Vascular Endothelial Growth Factor Therapies as a Novel Therapeutic Approach to Treating Neurofibromatosis-Related Tumors за авторством Hon Kit Wong, Johanna Lahdenranta, Walid S. Kamoun, Annie W. Chan, Andrea I. McClatchey, Scott R. Plotkin, Rakesh K. Jain, Emmanuelle di Tomaso
Опубліковано 2010Artigo -
18
Relationship between whole‐body tumor burden, clinical phenotype, and quality of life in patients with neurofibromatosis за авторством Vanessa L. Merker, Miriam A. Bredella, Wenli Cai, Ara Kassarjian, Gordon J. Harris, Alona Muzikansky, Rosa Nguyen, Victor F. Mautner, Scott R. Plotkin
Опубліковано 2014Artigo -
19
Self-reported access to specialty clinics and receipt of health surveillance among U.S. patients with neurofibromatosis 1: a national survey за авторством Vanessa L. Merker, Yidan Ma, Lori B. Chibnik, Heather B. Radtke, Kate Kelts, Kaleb Yohay, Nicole J. Ullrich, Scott R. Plotkin, Justin T. Jordan
Опубліковано 2025Artigo -
20
Use of Video to Facilitate End-of-Life Discussions With Patients With Cancer: A Randomized Controlled Trial за авторством Areej El‐Jawahri, Lisa Podgurski, April F. Eichler, Scott R. Plotkin, Jennifer S. Temel, Susan L. Mitchell, Yuchiao Chang, Michael J. Barry, Angelo E. Volandes
Опубліковано 2009Artigo
Інструменти для пошуку:
Пов'язані теми
Medicine
Internal medicine
Neurofibromatosis
Pathology
Oncology
Chemotherapy
Neurofibromatosis type 2
Surgery
Biology
Cancer
Bevacizumab
Cancer research
Radiology
Schwannoma
Clinical trial
Gastroenterology
Environmental health
Population
Audiology
Genetics
Hearing loss
Adverse effect
Radiation therapy
VEGF receptors
Vascular endothelial growth factor
Cohort
Gene
Meningioma
Mutation
Biochemistry